scholarly journals Pathways to the diagnosis of lung cancer in the UK: a cohort study

2008 ◽  
Vol 9 (1) ◽  
Author(s):  
Jacqueline Barrett ◽  
William Hamilton
Keyword(s):  
Lung Cancer ◽  
Cohort Study ◽  
Diagnosis Of Lung Cancer ◽  
The Uk

A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer

2016 ◽  
Vol 77 (12) ◽  
pp. e1626-e1630 ◽  
Author(s):  
Daniel W. Bradford ◽  
Joseph Goulet ◽  
Marcia Hunt ◽  
Natasha C. Cunningham ◽  
Rani Hoff
Keyword(s):  
Lung Cancer ◽  
Cohort Study ◽  
Diagnosis Of Lung Cancer

scholarly journals Survival of Indigenous and non‐Indigenous Queenslanders after a diagnosis of lung cancer: a matched cohort study

2008 ◽  
Vol 188 (10) ◽  
pp. 562-566 ◽  
Author(s):  
Michael D Coory ◽  
Adele C Green ◽  
Janelle Stirling ◽  
Patricia C Valery
Keyword(s):  
Lung Cancer ◽  
Cohort Study ◽  
Matched Cohort ◽  
Matched Cohort Study ◽  
Diagnosis Of Lung Cancer

Known diagnosis of lung cancer

2007 ◽  
pp. 231-236
Keyword(s):  
Lung Cancer ◽  
Respiratory Disease ◽  
Respiratory Symptoms ◽  
Cancer Death ◽  
Common Cause ◽  
Assessment And Evaluation ◽  
Diagnosis Of Lung Cancer ◽  
The Uk ◽  
Primary Problem

Introduction 232 Respiratory symptoms related to lung cancer 232 Primarily non-respiratory symptoms related to lung cancer 233 Attendance as a complication of therapy 233 Presentation with unrelated illness 234 Assessment and evaluation 234 Management 234 Lung cancer is the most common cause of cancer death in the UK and therefore is likely to present to the acute physician at some time. This chapter deals briefly with lung cancer itself; for more detailed information see OHRM, Chapter 18. Patients with a known diagnosis of lung cancer may present acutely with symptoms due to the primary problem of the lung cancer itself (which may or may not be with primarily respiratory symptoms), complications of treatment, or a respiratory presentation due to coexisting respiratory disease....

scholarly journals Methylation Assay for the Diagnosis of Lung Cancer on Bronchial Aspirates: A Cohort Study

2005 ◽  
Vol 11 (21) ◽  
pp. 7728-7734 ◽  
Author(s):  
Viola Schmiemann ◽  
Alfred Böcking ◽  
Marietta Kazimirek ◽  
Alexandre Sherlley Casimiro Onofre ◽  
Helmut Erich Gabbert ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cohort Study ◽  
Methylation Assay ◽  
Diagnosis Of Lung Cancer

scholarly journals Estimating lung cancer risk from chest X-ray and symptoms: a prospective cohort study

2020 ◽  
pp. bjgp20X713993
Author(s):  
Stephen H Bradley ◽  
Nathaniel Luke Fielding Hatton ◽  
Rehima Aslam ◽  
Bobby Bhartia ◽  
Matthew EJ Callister ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cohort Study ◽  
Sensitivity And Specificity ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Diagnostic Category ◽  
Predictive Values ◽  
X Ray ◽  
Chest X Ray ◽  
Diagnosis Of Lung Cancer

BackgroundChest X-ray (CXR) is the first-line investigation for lung cancer in many countries but previous research has suggested that the disease is not detected by CXR in approximately 20% of patients. The risk of lung cancer, with particular symptoms, following a negative CXR is not known.AimTo establish the sensitivity and specificity of CXR requested by patients who are symptomatic; determine the positive predictive values (PPVs) of each presenting symptom of lung cancer following a negative CXR; and determine whether symptoms associated with lung cancer are different in those who had a positive CXR result compared with those who had a negative CXR result.Design and settingA prospective cohort study was conducted in Leeds, UK, based on routinely collected data from a service that allowed patients with symptoms of lung cancer to request CXR.MethodSymptom data were combined with a diagnostic category (positive or negative) for each CXR, and the sensitivity and specificity of CXR for lung cancer were calculated. The PPV of lung cancer associated with each symptom or combination of symptoms was estimated for those patients with a negative CXR.ResultsIn total, 114 (1.3%) of 8996 patients who requested a CXR were diagnosed with lung cancer within 1 year. Sensitivity was 75.4% and specificity was 90.2%. The PPV of all symptoms for a diagnosis of lung cancer within 1 year of CXR was <1% for all individual symptoms except for haemoptysis, which had a PPV of 2.9%. PPVs for a diagnosis of lung cancer within 2 years of CXR was <1.5% for all single symptoms except for haemoptysis, which had a PPV of 3.9%.ConclusionCXR has limited sensitivity; however, in a population with a low prevalence of lung cancer, its high specificity and negative predictive value means that lung cancer is very unlikely to be present following a negative result. Findings also support guidance that unexplained haemoptysis warrants urgent referral, regardless of CXR result.

Three-channel intelligent neoplasm classification system for the diagnosis of lung cancer

2019 ◽  
Vol 7 (3) ◽  
pp. 196-207
Author(s):  
Lev Utkin ◽  
Anna Meldo ◽  
Viktor Kryshtapovich ◽  
Viktor Tiulpin ◽  
Ernest Kasimov ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Classification System ◽  
Diagnosis Of Lung Cancer
Sign in / Sign up

Export Citation Format

Share Document